Placeholder text

Go to cart

Neurophysiologic Biomarkers in Neuropsychiatric Disorders

By Javitt, Daniel C.

Neurophysiologic Biomarkers in Neuropsychiatric Disorders Medicine

Neurophysiologic Biomarkers in Neuropsychiatric Disorders

0 - Default Title
Description
This book reviews neurophysiological biomarkers in neuropsychiatric disorders from the viewpoint of the 21st Century Cures Act, which encourages the use of biomarkers for a variety of purposes during drug development. It covers both traditional etiologic uses of biomarkers and the more recent Biomarkers, EndpointS, and other Tools (BEST) classification scheme used by the FDA, which permits biomarkers for purposes of susceptibility, diagnosis, monitoring, prognosis, pharmacodynamics/response, and safety. The first section of the book describes potential uses of neurophysiologic biomarkers. Subsequent sections focus on a wide range of conditions, including schizophrenia, autism spectrum disorder, Parkinson's disease, and depression, as well as cross-diagnostic and translational uses, including monkey and rodent analogs. The purpose of the book is to help clinicians understand how neurophysiological biomarkers may be used to understand and manage clinical conditions; to help researchers to understand how biomarkers may be used translationally to test specific theories; and to help pharma investigators to understand how biomarkers can be used to accelerate treatment development.
Product details
Binding:
Paperback
Number of Pages:
856
Release Date:
2025-11-20
Publication Date:
2025-11-20
Publisher:
Springer
Languages:
Original: English
ISBN10:
3031694937
ISBN13:
9783031694936
GPSR Manufacturer Reference:
[email protected]
Weight:
1270 g
Height:
155 cm
Width:
235 cm
Thickness:
46 cm
Buy on Amazon
Currently sold out